Using ultra‑high‑frequency ECG to distinguish true LBBB and guide whether left bundle branch or biventricular pacing is best
Official title: The Role of Ultra-high-frequency ECG in the Localization of Left Ventricular Conduction Disorders and Prediction of Response to Resynchronization Therapy
Run by Faculty Hospital Kralovske Vinohrady · NCT07057544 · Data updated 2026-11-12
We will test whether ultra‑high‑frequency ECG can tell 'true' left bundle branch block from other intraventricular conduction delays and see if people with heart failure and a wide non‑RBBB QRS do better with left bundle branch pacing than with biventricular pacing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Faculty Hospital Kralovske Vinohrady Government |
| Locations | 1 site (Prague, Česká Republika) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | July 14, 2025 |
| Trial ID | NCT07057544 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with ischemic or non‑ischemic cardiomyopathy, NYHA class II–IV, LVEF ≤40%, known coronary angiography, and a non‑RBBB QRS duration >130 ms are the intended candidates.
✕Probably not a fit
People with right bundle branch block, QRS <130 ms, reversible causes of heart failure, recent major cardiac events or surgery, severe valvular disease requiring intervention, or life expectancy under one year are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional project uses ultra‑high‑frequency ECG (UHF‑ECG) to map ventricular activation patterns and distinguish proximal ('true') LBBB from more distal intraventricular conduction delay (IVCD). Patients with heart failure, LVEF ≤40%, NYHA II–IV and non‑RBBB QRS ≥130 ms will undergo UHF‑ECG and either invasive EP confirmation or validated non‑invasive dyssynchrony assessment, then receive CRT by left bundle branch area pacing (LBBAP) or biventricular pacing (BVP). The study compares electrical dyssynchrony changes, echocardiographic remodeling, and clinical response between groups to see which pacing approach gives greater improvement in patients identified as true LBBB. Pilot data guiding the protocol suggest distinct activation patterns on UHF‑ECG and larger dyssynchrony in true LBBB patients.
Why it matters
Potential benefit: If successful, this approach could help match each patient to the CRT method most likely to improve heart function and symptoms.
How similar studies have gone: Pilot studies and early reports indicate conduction‑system pacing can outperform biventricular pacing in some patients with true LBBB, but randomized evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * HF due to ischemic or non-ischemic cardiomyopathy * known coronary angiography * NYHA II-IV * LVEF ≤40% * non-RBBB QRSd lasting \>130 ms (by automated measurement) * proximal LBBB proved by an invasive EP study or non-invasive dyssynchrony assessment in case such a method is confirmed to be non-inferior to an invasive EP study during the project Exclusion Criteria: * Age ˂18 years * heart failure from reversible causes * Moderate to severe aortic stenosis * pregnancy * active myocarditis * hypertrophic cardiomyopathy * cardiac valve surgery in the last three months * myocardial infarction, PCI, or CABG in the last three months * severe valvular disease requiring intervention * severe atherosclerotic disease of the aorta and/or femoral arteries * life expectancy ˂1 year * known medical condition or contraindication causing potential complications for EP study
Where it's running
-
Faculty Hospital Kralovske Vinohrady
Prague, Česká Republika, Czechia Recruiting
Study contacts
- Study coordinator: Karol Curila, MD
- Email: karol.curila@fnkv.cz
- Phone: +420777869171
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Left bundle branch area pacing with multimodal guidance vs. conventional pacing for heart failure with complete left bundle branch block
A multicenter trial tests whether using multimodal data to guide left bundle branch area pacing helps people with heart failure and complete left bundle branch block, compared with traditional biventricular pacing.
-
ML-based diagnosis of blocked arteries in patients with a left bundle branch block
Doctors are testing a machine learning tool that uses digital ECGs to see if a blocked coronary artery is present in patients with a left bundle branch block.
-
LINEA pacing lead for septal placement in pacemaker patients
This study tests the safety and performance of a new LINEA cardiac pacing lead for patients getting a new pacemaker with septal placement.
-
Lead-related tricuspid valve leakage after first-time pacemaker or ICD implantation
This project will see if a new transvenous pacemaker or ICD lead causes new or worse tricuspid valve regurgitation in people getting their first device.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
Evaluating different approaches to cardiac pacing in patients
This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.